Huiyu Pharmaceutical: Simididine injection obtained drug registration certificate

Huiyu Pharmaceutical announced that it recently received the "Drug Registration Certificate" for the company's product Cimetidine Injection approved and issued by the National Medical Products Administration. Cimetidine Injection is mainly indicated for gastrointestinal ulcers. The original research Cimetidine Injection from Sumitomo Pharma Co., Ltd. has not yet been launched in the domestic market. Currently, there are 11 domestic enterprises that hold approvals for Cimetidine Injection and have passed or are deemed to have passed the evaluation of generic drug quality and efficacy consistency, including Huiyu Pharmaceutical, Jiangsu Lianshui, Shanxi Nuocheng, and other companies.